{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:53:53Z","timestamp":1788872033991,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.hoc.2009.01.009","type":"journal-article","created":{"date-parts":[[2009,3,26]],"date-time":"2009-03-26T05:28:43Z","timestamp":1238045323000},"page":"249-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Diagnosis and Management of Acquired Pure Red Cell Aplasia"],"prefix":"10.1016","volume":"23","author":[{"given":"Kenichi","family":"Sawada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hirokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohito","family":"Fujishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2009.01.009_bib1","series-title":"Pure red cell aplasia","author":"Dessypris","year":"1988"},{"key":"10.1016\/j.hoc.2009.01.009_bib2","series-title":"Wintrobe's clinical hematology","first-page":"1421","article-title":"Red cell aplasia","author":"Dessypris","year":"2004"},{"issue":"5130","key":"10.1016\/j.hoc.2009.01.009_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1126\/science.8211117","article-title":"Erythrocyte P antigen: cellular receptor for parvovirus B19","volume":"262","author":"Brown","year":"1993","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.hoc.2009.01.009_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2141.1995.tb05250.x","article-title":"Management of persistent B19 parvovirus infection in AIDS","volume":"91","author":"Ramratnam","year":"1995","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.hoc.2009.01.009_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ajh.2830230408","article-title":"Pure red cell aplasia: response to therapy with anti-thymocyte globulin","volume":"23","author":"Abkowitz","year":"1986","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.hoc.2009.01.009_bib6","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1182\/blood.V87.11.4831.bloodjournal87114831","article-title":"The pathophysiology of pure red cell aplasia: implications for therapy","volume":"87","author":"Charles","year":"1996","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2009.01.009_bib7","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1182\/blood.V87.7.3000.bloodjournal8773000","article-title":"Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities","volume":"87","author":"Lacy","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.01.009_bib8","series-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","first-page":"274","article-title":"Chronic lymphoproliferative disorders of NK cells","author":"Villamor","year":"2008"},{"issue":"4","key":"10.1016\/j.hoc.2009.01.009_bib9","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1365-2141.2000.02429.x","article-title":"Pure red cell aplasia","volume":"111","author":"Fisch","year":"2000","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.hoc.2009.01.009_bib10","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1172\/JCI110713","article-title":"Tg (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia","volume":"70","author":"Mangan","year":"1982","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.hoc.2009.01.009_bib11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199901283400405","article-title":"Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors","volume":"340","author":"Handgretinger","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.hoc.2009.01.009_bib12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1073\/pnas.58.2.493","article-title":"Studies on red cell aplasia. I. Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei","volume":"58","author":"Krantz","year":"1967","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.hoc.2009.01.009_bib13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJMoa011931","article-title":"Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin","volume":"346","author":"Casadevall","year":"2002","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.hoc.2009.01.009_bib14","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJMoa040528","article-title":"Pure red-cell aplasia and epoetin therapy","volume":"351","author":"Bennett","year":"2004","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.hoc.2009.01.009_bib15","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood.V98.6.1687","article-title":"Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation","volume":"98","author":"Bolan","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2009.01.009_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-0609.1997.tb00978.x","article-title":"Acquired pure red cell aplasia in Japan","volume":"59","author":"Mamiya","year":"1997","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2009.01.009_bib17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2141.2006.06295.x","article-title":"Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience","volume":"135","author":"Thompson","year":"2006","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2009.01.009_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3324\/haematol.11655","article-title":"Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia","volume":"93","author":"Hirokawa","year":"2008","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.hoc.2009.01.009_bib19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ajh.2830420229","article-title":"Cyclosporine A used as a single drug in the treatment of pure red cell aplasia associated with thymoma","volume":"42","author":"Garcia Vela","year":"1993","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.hoc.2009.01.009_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ajh.2830230211","article-title":"Autoreactive erythroid progenitor-T suppressor cells in the pure red cell aplasia associated with thymoma and panhypogammaglobulinemia","volume":"23","author":"Mangan","year":"1986","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.hoc.2009.01.009_bib21","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/(SICI)1096-8652(199704)54:4<324::AID-AJH12>3.0.CO;2-B","article-title":"Pure red cell aplasia with thymoma: evidence of T-cell clonal disorder","volume":"54","author":"Masuda","year":"1997","journal-title":"Am J Hematol"},{"issue":"Suppl 12","key":"10.1016\/j.hoc.2009.01.009_bib22","first-page":"e128","article-title":"Oligoclonal T cell expansion in blood but not in the thymus from a patient with thymoma-associated pure red cell aplasia","volume":"91","author":"Fujishima","year":"2006","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.hoc.2009.01.009_bib23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/jcp.44.5.431","article-title":"Red cell aplasia in myelodysplastic syndrome","volume":"44","author":"Williamson","year":"1991","journal-title":"J Clin Pathol"},{"issue":"6","key":"10.1016\/j.hoc.2009.01.009_bib24","first-page":"782","article-title":"Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders","volume":"7","author":"Oshimi","year":"1993","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.hoc.2009.01.009_bib25","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ajh.21241","article-title":"Combined pure red cell aplasia and autoimmune hemolytic anemia in systemic lupus erythematosus with anti-erythropoietin autoantibodies","volume":"83","author":"Hara","year":"2008","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.hoc.2009.01.009_bib26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.leukres.2007.08.012","article-title":"Acquired amegakaryocytic thrombocytopenia and pure red cell aplasia associated with an occult large granular lymphocyte leukemia","volume":"32","author":"Lai","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.hoc.2009.01.009_bib27","series-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","first-page":"272","article-title":"T-cell large granular lymphocyte leukaemia","author":"Chan","year":"2008"},{"issue":"3","key":"10.1016\/j.hoc.2009.01.009_bib28","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood.V99.3.1092","article-title":"Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia","volume":"99","author":"Ghazal","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2009.01.009_bib29","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1365-2141.2001.03039.x","article-title":"The effect of treatment with Campath-1H in patients with autoimmune cytopenias","volume":"114","author":"Willis","year":"2001","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.hoc.2009.01.009_bib30","first-page":"220","article-title":"Epoetin-induced pure red cell aplasia successfully treated with androgens","volume":"19","author":"S\u00e1nchez de la Nieta","year":"2006","journal-title":"J Nephrol"},{"issue":"2","key":"10.1016\/j.hoc.2009.01.009_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood.V63.2.277.277","article-title":"Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients","volume":"63","author":"Clark","year":"1984","journal-title":"Blood"},{"issue":"2\u20133","key":"10.1016\/j.hoc.2009.01.009_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02076698","article-title":"Pure red cell aplasia: review of treatment and proposal for a treatment strategy","volume":"61","author":"Raghavachar","year":"1990","journal-title":"Blut"},{"issue":"4","key":"10.1016\/j.hoc.2009.01.009_bib33","first-page":"285","article-title":"Therapy of pure red cell aplasia","volume":"28","author":"Marmont","year":"1991","journal-title":"Semin Hematol"},{"issue":"8","key":"10.1016\/j.hoc.2009.01.009_bib34","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3324\/haematol.11192","article-title":"Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A: a nationwide cohort study in Japan for the PRCA Collaborative Study Group","volume":"92","author":"Sawada","year":"2007","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.hoc.2009.01.009_bib35","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0609.1989.tb01201.x","article-title":"Treatment of pure red-cell aplasia and aplastic anaemia with ciclosporin: long-term clinical effects","volume":"42","author":"T\u00f6tterman","year":"1989","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.hoc.2009.01.009_bib36","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/ki.1995.161","article-title":"A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group","volume":"47","author":"Cattran","year":"1995","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.hoc.2009.01.009_bib37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood.V98.2.483","article-title":"Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes","volume":"98","author":"Go","year":"2001","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2009.01.009_bib38","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood.V84.5.1620.1620","article-title":"Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?","volume":"84","author":"Dhodapkar","year":"1994","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2009.01.009_bib39","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood.V84.7.2164.2164","article-title":"Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate","volume":"84","author":"Loughran","year":"1994","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2009.01.009_bib40","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/cncr.22032","article-title":"T-cell large granular lymphocyte leukemia: a report on the treatment of 29 patients and a review of the literature","volume":"107","author":"Osuji","year":"2006","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.hoc.2009.01.009_bib41","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3324\/haematol.12871","article-title":"Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group","volume":"93","author":"Fujishima","year":"2008","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.hoc.2009.01.009_bib42","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","article-title":"An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients","volume":"43","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.hoc.2009.01.009_bib43","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7326\/0003-4819-124-5-199603010-00003","article-title":"Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis","volume":"124","author":"Talar-Williams","year":"1996","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.hoc.2009.01.009_bib44","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1542\/peds.2006-1360","article-title":"Successful intermittent prophylaxis with trimethoprim\/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients","volume":"120","author":"Lindemulder","year":"2007","journal-title":"Pediatrics"},{"issue":"24","key":"10.1016\/j.hoc.2009.01.009_bib45","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858809000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858809000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:52:52Z","timestamp":1760183572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858809000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0889858809000100"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2009.01.009","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Management of Acquired Pure Red Cell Aplasia","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2009.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}